No abstract available
MeSH terms
-
Adolescent
-
Allografts
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bendamustine Hydrochloride / administration & dosage
-
Brentuximab Vedotin
-
Combined Modality Therapy
-
Drug Resistance, Neoplasm
-
Epstein-Barr Virus Infections / drug therapy*
-
Female
-
Hematopoietic Stem Cell Transplantation
-
Herpesvirus 4, Human / isolation & purification
-
Humans
-
Immunoconjugates / administration & dosage
-
Immunophenotyping
-
Ki-1 Antigen / analysis
-
Ki-1 Antigen / immunology
-
Lymphoma, Extranodal NK-T-Cell / drug therapy*
-
Lymphoma, Extranodal NK-T-Cell / therapy
-
Lymphoma, Extranodal NK-T-Cell / virology
-
Lymphoma, Primary Cutaneous Anaplastic Large Cell / drug therapy*
-
Lymphoma, Primary Cutaneous Anaplastic Large Cell / therapy
-
Lymphoma, Primary Cutaneous Anaplastic Large Cell / virology
-
RNA, Viral / analysis
-
Remission Induction
-
Salvage Therapy*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / therapy
-
Skin Neoplasms / virology
-
Tumor Virus Infections / drug therapy*
Substances
-
Epstein-Barr virus encoded RNA 1
-
Epstein-Barr virus encoded RNA 2
-
Immunoconjugates
-
Ki-1 Antigen
-
RNA, Viral
-
Brentuximab Vedotin
-
Bendamustine Hydrochloride